| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |